US Foods Reports Fourth Quarter and Fiscal Year 2021 Earnings
US Foods Holding Corp. reported strong fiscal results for 2021, with net sales increasing 28.8% to $29.5 billion. Fourth-quarter net sales rose 24.5% to $7.6 billion. Total case volume grew 16.9%, driven by increased restaurant traffic post-COVID restrictions. Adjusted EBITDA surged 63.1% to $1,057 million. The company expects Adjusted EBITDA of $1.2-$1.3 billion for fiscal 2022, with a long-term goal of $1.7 billion by 2024. CEO Pietro Satriano highlighted resilience amid supply chain challenges and a focus on profitable growth.
- Net sales increased 28.8% to $29.5 billion for FY 2021.
- Adjusted EBITDA rose 63.1% to $1,057 million for FY 2021.
- Total case volume increased 16.9% for FY 2021, driven by restaurant recovery.
- Diluted EPS for FY 2021 was $0.54, with Adjusted Diluted EPS at $1.55.
- Long-term forecast expects Adjusted EBITDA of approximately $1.7 billion by 2024.
- Operating expenses increased 11.5% to $4.2 billion for FY 2021.
Provides Outlook for 2022 and 2024
Fourth Quarter Fiscal 2021 Highlights
-
Total case volume increased
6.3% ; independent restaurant case volume increased13.0% . Excluding the extra week, total case volume increased13.0% and independent restaurant case volume increased20.6% . -
Net sales increased
24.5% to .$7.6 billion -
Gross profit increased
23.2% to .$1.2 billion -
Net income available to common shareholders was
.$59 million -
Adjusted EBITDA increased
50.6% to . The extra week contributed approximately$262 million to Adjusted EBITDA in 2020.$8 million -
Diluted EPS was
; Adjusted Diluted EPS was$0.26 .$0.38
Fiscal Year 2021 Highlights
-
Total case volume increased
16.9% ; independent restaurant case volume increased28.0% . Excluding the extra week, total case volume increased18.8% and independent restaurant case volume increased30.2% . -
Total organic case volume increased
14.8% ; independent restaurant organic case volume increased25.1% . Excluding the extra week, total organic case volume increased16.6% and organic independent restaurant case volume increased27.1% . -
Net sales increased
28.8% to .$29.5 billion -
Gross profit increased
25.2% to .$4.7 billion -
Net income available to common shareholders was
.$121 million -
Adjusted EBITDA increased
63.1% to .$1,057 million -
Diluted EPS was
; Adjusted Diluted EPS was$0.54 .$1.55
Long-Range Plan
- Multi-year plan, which is expected to result in significant earnings growth from the combination of profitable volume growth and margin expansion.
-
Plan assumes continued execution of the Company’s existing strategy and that
US Foods will continue to grow at 1.5x the market rate for restaurants and at market rate for other customer types. -
Expects to deliver Adjusted EBITDA of approximately
and Adjusted Diluted EPS of approximately$1.7 billion in 2024.$3.40 - Expects to achieve Net Debt to Adjusted EBITDA leverage of 2.5x-3x in 2023.
CEO Perspective
“2021 was a year of resilience and recovery. Thanks to the efforts of our associates, we stayed true to our promise to help our customers Make It," said CEO
Fourth Quarter Fiscal 2021 Results
Total case volume increased
Gross profit of
Operating expenses of
Net income available to common shareholders was
Fiscal Year 2021 Results
Total case volume increased
Gross profit of
Operating expenses of
Net income available to common shareholders was
Cash Flow and Debt
Net cash provided by operating activities for fiscal 2021 was
Net Debt at the end of fiscal year 2021 was
Outlook for Fiscal Years 2022 and 20241
In Fiscal 2022, the Company expects Adjusted EBITDA of
The Company expects to deliver Adjusted EBITDA of approximately
1 The Company is not providing a reconciliation of certain forward-looking non-GAAP financial measures, including Adjusted EBITDA and Adjusted Diluted EPS, because the Company is unable to predict with reasonable certainty the financial impact of certain significant items, including restructuring costs and asset impairment charges, share-based compensation expenses, non-cash impacts of LIFO reserve adjustments, losses on extinguishments of debt, business transformation costs, other gains and losses, business acquisition and integration related costs and diluted earnings per share. These items are uncertain, depend on various factors, and could have a material impact on GAAP reported results for the guidance periods. For the same reasons, the Company is unable to address the significance of the unavailable information, which could be material to future results.
Conference Call and Webcast Information
Presentation slides will be available shortly before the webcast begins. The webcast, slides, and a copy of this press release can be found in the Investor Relations section of our website at https://ir.usfoods.com.
About
With a promise to help its customers Make It,
Forward-Looking Statements
Statements in this press release which are not historical in nature, including those under the heading “Outlook for Fiscal Years 2022 and 2024,” are “forward-looking statements” within the meaning of the federal securities laws. These statements often include words such as “believe,” “expect,” “project,” “anticipate,” “intend,” “plan,” “outlook,” “estimate,” “target,” “seek,” “will,” “may,” “would,” “should,” “could,” “forecast,” “mission,” “strive,” “more,” “goal,” or similar expressions (although not all forward-looking statements may contain such words) and are based upon various assumptions and our experience in the industry, as well as historical trends, current conditions, and expected future developments. However, you should understand that these statements are not guarantees of performance or results and there are a number of risks, uncertainties and other important factors that could cause our actual results to differ materially from those expressed in the forward-looking statements, including, among others: economic factors affecting consumer confidence and discretionary spending and reducing the consumption of food prepared away from home; the extent and duration of the negative impact of the COVID-19 pandemic on us; cost inflation/deflation and commodity volatility; competition; reliance on third party suppliers and interruption of product supply or increases in product costs; changes in our relationships with customers and group purchasing organizations; our ability to increase or maintain the highest margin portions of our business; achievement of expected benefits from cost savings initiatives; increases in fuel costs; changes in consumer eating habits; cost and pricing structures; impairment charges for goodwill, indefinite-lived intangible assets or other long-lived assets; environmental, health and safety and other governmental regulation, including actions taken by national, state and local governments to contain the COVID-19 pandemic, such as travel restrictions or bans, social distancing requirements, and required closures of non-essential businesses; product recalls and product liability claims; our reputation in the industry; indebtedness and restrictions under agreements governing our indebtedness; interest rate increases; changes in the method of determining London Interbank Offered Rate (“LIBOR”) or the replacement of LIBOR with an alternative reference rate; labor relations and increased labor costs and continued access to qualified and diverse labor; risks associated with intellectual property, including potential infringement; disruption of existing technologies and implementation of new technologies; cybersecurity incidents and other technology disruptions; effective integration of acquired businesses; changes in tax laws and regulations and resolution of tax disputes; adverse judgments or settlements resulting from litigation; extreme weather conditions, natural disasters and other catastrophic events, including pandemics and the rapid spread of contagious illnesses; costs and risks associated with current and changing government laws and regulations, and potential changes as a result of initiatives by the Biden administration; management of retirement benefits and pension obligations; and potential costs associated with shareholder activism.
For a detailed discussion of these risks, uncertainties and other factors that could cause our results to differ materially from those anticipated or expressed in any forward-looking statements, see the section entitled “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended
Non-GAAP Financial Measures
We report our financial results in accordance with
We use Adjusted Gross profit and Adjusted Operating expenses as supplemental measures to GAAP measures to focus on period-over-period changes in our business and believe this information is helpful to investors. Adjusted Gross profit is Gross profit adjusted to remove the impact of the LIFO inventory reserve adjustments. Adjusted Operating expenses are Operating expenses adjusted to exclude amounts that we do not consider part of our core operating results when assessing our performance.
We believe EBITDA and Adjusted EBITDA provide meaningful supplemental information about our operating performance because they exclude amounts that we do not consider part of our core operating results when assessing our performance. EBITDA is Net income (loss), plus Interest expense-net, Income tax provision (benefit), and Depreciation and amortization. Adjusted EBITDA is EBITDA adjusted for (1) Restructuring costs and asset impairment charges; (2) Share-based compensation expense; (3) the non-cash impact of LIFO reserve adjustments; (4) loss on extinguishment of debt; (5) Business transformation costs; and (6) other gains, losses or costs as specified in the agreements governing our indebtedness.
We use Net Debt as a supplemental measure to GAAP measures to review the liquidity of our operations. Net Debt is defined as total debt net of total Cash, cash equivalents and restricted cash remaining on the balance sheet as of the end of the most recent fiscal quarter. We believe that Net Debt is a useful financial metric to assess our ability to pursue business opportunities and investments. Net Debt is not a measure of our liquidity under GAAP and should not be considered as an alternative to Cash Flows Provided by Operations or Cash Flows Used in Financing Activities.
We believe that Adjusted Net income (loss) is a useful measure of operating performance for both management and investors because it excludes items that are not reflective of our core operating performance and provides an additional view of our operating performance including depreciation, interest expense, and Income taxes on a consistent basis from period to period. Adjusted Net income (loss) is Net income (loss) excluding such items as restructuring costs and asset impairment charges, Share-based compensation expense, the non-cash impacts of LIFO reserve adjustments, loss on extinguishment of debt, Business transformation costs and other items, and adjusted for the tax effect of the exclusions and discrete tax items. We believe that Adjusted Net income (loss) may be used by investors, analysts, and other interested parties to facilitate period-over-period comparisons and provides additional clarity as to how factors and trends impact our operating performance.
We use Adjusted Diluted Earnings per Share, which is calculated by adjusting the most directly comparable GAAP financial measure, Diluted Earnings per Share, by excluding the same items excluded in our calculation of Adjusted EBITDA to the extent that each such item was included in the applicable GAAP financial measure. We believe the presentation of Adjusted Diluted Earnings per Share is useful to investors because the measurement excludes amounts that we do not consider part of our core operating results when assessing our performance. We also believe that the presentation of Adjusted EBITDA and Adjusted Diluted Earnings per Share is useful to investors because these metrics may be used by securities analysts, investors and other interested parties in their evaluation of the operating performance of companies in our industry.
Management uses these non-GAAP financial measures (a) to evaluate our historical and prospective financial performance as well as our performance relative to our competitors as they assist in highlighting trends, (b) to set internal sales targets and spending budgets, (c) to measure operational profitability and the accuracy of forecasting, (d) to assess financial discipline over operational expenditures, and (e) as an important factor in determining variable compensation for management and employees. EBITDA and Adjusted EBITDA are also used in connection with certain covenants and restricted activities under the agreements governing our indebtedness. We also believe these and similar non-GAAP financial measures are frequently used by securities analysts, investors, and other interested parties to evaluate companies in our industry.
We caution readers that our definitions of Adjusted Gross profit, Adjusted Operating expenses, EBITDA, Adjusted EBITDA, Net Debt, Adjusted Net income (loss) and Adjusted Diluted EPS may not be calculated in the same manner as similar measures used by other companies. Definitions and reconciliations of the non-GAAP financial measures to their most comparable GAAP financial measures are included in the schedules attached to this press release.
Consolidated Balance Sheets (Unaudited) |
||||||||
($ in millions) |
|
|
|
|
||||
|
|
|
|
|
||||
ASSETS |
|
|
|
|
||||
Current assets |
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
148 |
|
|
$ |
828 |
|
Accounts receivable, less allowances of |
|
|
1,469 |
|
|
|
1,084 |
|
Vendor receivables, less allowances of |
|
|
145 |
|
|
|
121 |
|
Inventories—net |
|
|
1,686 |
|
|
|
1,273 |
|
Prepaid expenses |
|
|
120 |
|
|
|
132 |
|
Assets held for sale |
|
|
8 |
|
|
|
1 |
|
Other current assets |
|
|
18 |
|
|
|
26 |
|
Total current assets |
|
|
3,594 |
|
|
|
3,465 |
|
Property and equipment—net |
|
|
2,033 |
|
|
|
2,021 |
|
|
|
|
5,625 |
|
|
|
5,637 |
|
Other intangibles—net |
|
|
830 |
|
|
|
892 |
|
Deferred tax assets |
|
|
8 |
|
|
|
1 |
|
Other assets |
|
|
431 |
|
|
|
407 |
|
Total assets |
|
$ |
12,521 |
|
|
$ |
12,423 |
|
|
|
|
|
|
||||
LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS' EQUITY |
|
|
|
|
||||
Current liabilities: |
|
|
|
|
||||
Cash overdraft liability |
|
$ |
183 |
|
|
$ |
136 |
|
Accounts payable |
|
|
1,662 |
|
|
|
1,218 |
|
Accrued expenses and other current liabilities |
|
|
610 |
|
|
|
497 |
|
Current portion of long-term debt |
|
|
95 |
|
|
|
131 |
|
Total current liabilities |
|
|
2,550 |
|
|
|
1,982 |
|
Long-term debt |
|
|
4,916 |
|
|
|
5,617 |
|
Deferred tax liabilities |
|
|
307 |
|
|
|
270 |
|
Other long-term liabilities |
|
|
479 |
|
|
|
505 |
|
Total liabilities |
|
|
8,252 |
|
|
|
8,374 |
|
Mezzanine equity: |
|
|
|
|
||||
Series A convertible preferred stock |
|
|
534 |
|
|
|
519 |
|
Shareholders' equity: |
|
|
|
|
||||
Common stock |
|
|
2 |
|
|
|
2 |
|
Additional paid-in capital |
|
|
2,970 |
|
|
|
2,901 |
|
Retained earnings |
|
|
782 |
|
|
|
661 |
|
Accumulated other comprehensive loss |
|
|
(19 |
) |
|
|
(34 |
) |
Total shareholders’ equity |
|
|
3,735 |
|
|
|
3,530 |
|
Total liabilities, mezzanine equity and shareholders' equity |
|
$ |
12,521 |
|
|
$ |
12,423 |
|
Consolidated Statements of Operations (Unaudited) |
||||||||||||||||
|
|
For the quarter ended |
|
For the year ended |
||||||||||||
($ in millions, except share and per share data) |
|
|
|
|
|
|
|
|
||||||||
Net sales |
|
$ |
7,639 |
|
|
$ |
6,138 |
|
|
$ |
29,487 |
|
|
$ |
22,885 |
|
Cost of goods sold |
|
|
6,397 |
|
|
|
5,130 |
|
|
|
24,832 |
|
|
|
19,166 |
|
Gross profit |
|
|
1,242 |
|
|
|
1,008 |
|
|
|
4,655 |
|
|
|
3,719 |
|
Distribution, selling and administrative costs |
|
|
1,105 |
|
|
|
978 |
|
|
|
4,220 |
|
|
|
3,757 |
|
Restructuring costs and asset impairment charges |
|
|
— |
|
|
|
— |
|
|
|
11 |
|
|
|
39 |
|
Total operating expenses |
|
|
1,105 |
|
|
|
978 |
|
|
|
4,231 |
|
|
|
3,796 |
|
Operating income (loss) |
|
|
137 |
|
|
|
30 |
|
|
|
424 |
|
|
|
(77 |
) |
Other income—net |
|
|
(7 |
) |
|
|
(5 |
) |
|
|
(26 |
) |
|
|
(21 |
) |
Interest expense—net |
|
|
55 |
|
|
|
60 |
|
|
|
213 |
|
|
|
238 |
|
Loss on extinguishment of debt |
|
|
— |
|
|
|
— |
|
|
|
23 |
|
|
|
— |
|
Income (loss) before income taxes |
|
|
89 |
|
|
|
(25 |
) |
|
|
214 |
|
|
|
(294 |
) |
Income tax provision (benefit) |
|
|
20 |
|
|
|
(15 |
) |
|
|
50 |
|
|
|
(68 |
) |
Net income (loss) |
|
$ |
69 |
|
|
$ |
(10 |
) |
|
$ |
164 |
|
|
$ |
(226 |
) |
|
|
|
|
|
|
|
|
|
||||||||
Net income (loss) |
|
$ |
69 |
|
|
$ |
(10 |
) |
|
$ |
164 |
|
|
$ |
(226 |
) |
Series A convertible preferred stock dividends |
|
|
(10 |
) |
|
|
(13 |
) |
|
|
(43 |
) |
|
|
(28 |
) |
Net income (loss) available to common shareholders |
|
$ |
59 |
|
|
$ |
(23 |
) |
|
$ |
121 |
|
|
$ |
(254 |
) |
|
|
|
|
|
|
|
|
|
||||||||
Net income (loss) per share |
|
|
|
|
|
|
|
|
||||||||
Basic |
|
$ |
0.26 |
|
|
$ |
(0.11 |
) |
|
$ |
0.55 |
|
|
$ |
(1.15 |
) |
Diluted |
|
$ |
0.26 |
|
|
$ |
(0.11 |
) |
|
$ |
0.54 |
|
|
$ |
(1.15 |
) |
|
|
|
|
|
|
|
|
|
||||||||
Weighted-average common shares outstanding |
|
|
|
|
|
|
|
|
||||||||
Basic |
|
|
222,583,630 |
|
|
|
220,373,388 |
|
|
|
221,864,507 |
|
|
|
219,838,120 |
|
Diluted |
|
|
225,709,620 |
|
|
|
220,373,388 |
|
|
|
225,231,760 |
|
|
|
219,838,120 |
|
Consolidated Statements of Cash Flows (Unaudited) |
||||||||
|
|
For the year ended |
||||||
($ in millions) |
|
|
|
|
||||
Cash Flows From Operating Activities: |
|
|
|
|
||||
Net income (loss) |
|
$ |
164 |
|
|
$ |
(226 |
) |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: |
|
|
|
|
||||
Depreciation and amortization |
|
|
378 |
|
|
|
422 |
|
Gain on disposal of property and equipment—net |
|
|
(1 |
) |
|
|
(17 |
) |
Tangible asset impairment charges |
|
|
1 |
|
|
|
3 |
|
Intangible asset impairment charges |
|
|
7 |
|
|
|
9 |
|
Loss on extinguishment of debt |
|
|
23 |
|
|
|
— |
|
Amortization of deferred financing costs |
|
|
15 |
|
|
|
16 |
|
Deferred tax provision (benefit) |
|
|
38 |
|
|
|
(51 |
) |
Share-based compensation expense |
|
|
48 |
|
|
|
40 |
|
(Benefit) provision for doubtful accounts |
|
|
(24 |
) |
|
|
63 |
|
Changes in operating assets and liabilities, net of business acquisitions: |
|
|
|
|
||||
(Increase) decrease in receivables |
|
|
(386 |
) |
|
|
334 |
|
(Increase) decrease in inventories |
|
|
(413 |
) |
|
|
201 |
|
Decrease (increase) in prepaid expenses and other assets |
|
|
4 |
|
|
|
(30 |
) |
Increase (decrease) in accounts payable and cash overdraft liability |
|
|
471 |
|
|
|
(339 |
) |
Increase (decrease) in accrued expenses and other liabilities |
|
|
94 |
|
|
|
(12 |
) |
Net cash provided by operating activities |
|
|
419 |
|
|
|
413 |
|
Cash Flows From Investing Activities: |
|
|
|
|
||||
Acquisition of businesses—net of cash |
|
|
— |
|
|
|
(972 |
) |
Proceeds from sales of divested assets |
|
|
5 |
|
|
|
7 |
|
Proceeds from sales of property and equipment |
|
|
7 |
|
|
|
44 |
|
Purchases of property and equipment |
|
|
(274 |
) |
|
|
(189 |
) |
Net cash used in investing activities |
|
|
(262 |
) |
|
|
(1,110 |
) |
Cash Flows From Financing Activities: |
|
|
|
|
||||
Proceeds from debt borrowings |
|
|
2,305 |
|
|
|
3,645 |
|
Principal payments on debt and financing leases |
|
|
(3,105 |
) |
|
|
(2,692 |
) |
Net proceeds from issuance of Series A convertible preferred stock |
|
|
— |
|
|
|
491 |
|
Dividends paid on Series A convertible preferred stock |
|
|
(28 |
) |
|
|
— |
|
Debt financing costs and fees |
|
|
(30 |
) |
|
|
(33 |
) |
Proceeds from employee stock purchase plan |
|
|
20 |
|
|
|
18 |
|
Proceeds from exercise of stock options |
|
|
15 |
|
|
|
3 |
|
Tax withholding payments for net share-settled equity awards |
|
|
(14 |
) |
|
|
(5 |
) |
Net cash (used in) provided by financing activities |
|
|
(837 |
) |
|
|
1,427 |
|
Net (decrease) increase in cash and cash equivalents |
|
|
(680 |
) |
|
|
730 |
|
Cash, cash equivalents and restricted cash—beginning of year |
|
|
828 |
|
|
|
98 |
|
Cash, cash equivalents and restricted cash—end of year |
|
$ |
148 |
|
|
$ |
828 |
|
Supplemental disclosures of cash flow information: |
|
|
|
|
||||
Interest paid—net of amounts capitalized |
|
$ |
185 |
|
|
$ |
216 |
|
Income taxes (received) paid—net |
|
|
1 |
|
|
|
(1 |
) |
Property and equipment purchases included in accounts payable |
|
|
40 |
|
|
|
21 |
|
Property and equipment transferred to assets held for sale |
|
|
11 |
|
|
|
24 |
|
Leased assets obtained in exchange for financing lease liabilities |
|
|
56 |
|
|
|
73 |
|
Leased assets obtained in exchange for operating lease liabilities |
|
|
32 |
|
|
|
48 |
|
Cashless exercise of stock options |
|
|
1 |
|
|
|
— |
|
Paid-in-kind Series A convertible preferred stock dividends |
|
|
15 |
|
|
|
28 |
|
Non-GAAP Reconciliation (Unaudited) |
|||||||||||||||
|
|
For the quarter ended |
|||||||||||||
|
|
Consolidated |
|||||||||||||
($ in millions, except share and per share data) |
|
|
|
|
|
Change |
|
% |
|||||||
Net income (loss) available to common shareholders (GAAP) |
|
$ |
59 |
|
|
$ |
(23 |
) |
|
$ |
82 |
|
|
NM |
|
Series A Preferred Stock Dividends |
|
|
(10 |
) |
|
|
(13 |
) |
|
|
3 |
|
|
(23.1 |
) % |
Net income (loss) (GAAP) |
|
|
69 |
|
|
|
(10 |
) |
|
|
79 |
|
|
NM |
|
Interest expense—net |
|
|
55 |
|
|
|
60 |
|
|
|
(5 |
) |
|
(8.3 |
) % |
Income tax provision (benefit) |
|
|
20 |
|
|
|
(15 |
) |
|
|
35 |
|
|
NM |
|
Depreciation expense |
|
|
81 |
|
|
|
86 |
|
|
|
(5 |
) |
|
(5.8 |
) % |
Amortization expense |
|
|
11 |
|
|
|
20 |
|
|
|
(9 |
) |
|
(45.0 |
) % |
EBITDA (Non-GAAP) |
|
|
236 |
|
|
|
141 |
|
|
|
95 |
|
|
67.4 |
% |
Adjustments: |
|
|
|
|
|
|
|
|
|||||||
Share-based compensation expense (1) |
|
|
12 |
|
|
|
11 |
|
|
|
1 |
|
|
9.1 |
% |
LIFO reserve adjustments (2) |
|
|
15 |
|
|
|
16 |
|
|
|
(1 |
) |
|
(6.3 |
) % |
Business transformation costs (3) |
|
|
5 |
|
|
|
14 |
|
|
|
(9 |
) |
|
(64.3 |
) % |
COVID-19 bad debt benefit (4) |
|
|
— |
|
|
|
(18 |
) |
|
|
18 |
|
|
(100.0 |
) % |
COVID-19 product donations and inventory adjustments (5) |
|
|
— |
|
|
|
10 |
|
|
|
(10 |
) |
|
(100.0 |
) % |
COVID-19 other related expenses (6) |
|
|
2 |
|
|
|
(2 |
) |
|
|
4 |
|
|
(200.0 |
) % |
Business acquisition and integration related costs and other (7) |
|
|
(8 |
) |
|
|
2 |
|
|
|
(10 |
) |
|
NM |
|
Adjusted EBITDA (Non-GAAP) |
|
|
262 |
|
|
|
174 |
|
|
|
88 |
|
|
50.6 |
% |
Depreciation expense |
|
|
(81 |
) |
|
|
(86 |
) |
|
|
5 |
|
|
(5.8 |
) % |
Interest expense—net |
|
|
(55 |
) |
|
|
(60 |
) |
|
|
5 |
|
|
(8.3 |
) % |
Income tax provision, as adjusted (8) |
|
|
(30 |
) |
|
|
(5 |
) |
|
|
(25 |
) |
|
NM |
|
Adjusted Net income (Non-GAAP) (9) |
|
$ |
96 |
|
|
$ |
23 |
|
|
$ |
73 |
|
|
NM |
|
|
|
|
|
|
|
|
|
|
|||||||
Diluted EPS (GAAP) |
|
$ |
0.26 |
|
|
$ |
(0.11 |
) |
|
$ |
0.37 |
|
|
NM |
|
Share-based compensation expense (1) |
|
|
0.05 |
|
|
|
0.05 |
|
|
|
— |
|
|
— |
% |
LIFO reserve adjustments (2) |
|
|
0.06 |
|
|
|
0.07 |
|
|
|
(0.01 |
) |
|
(14.3 |
) % |
Business transformation costs (3) |
|
|
0.02 |
|
|
|
0.06 |
|
|
|
(0.04 |
) |
|
(66.7 |
) % |
COVID-19 bad debt benefit (4) |
|
|
— |
|
|
|
(0.08 |
) |
|
|
0.08 |
|
|
(100.0 |
) % |
COVID-19 product donations and inventory adjustments (5) |
|
|
— |
|
|
|
0.05 |
|
|
|
(0.05 |
) |
|
(100.0 |
) % |
COVID-19 other related expenses (6) |
|
|
0.01 |
|
|
|
(0.01 |
) |
|
|
0.02 |
|
|
(200.0 |
) % |
Business acquisition and integration related costs and other (7) |
|
|
(0.03 |
) |
|
|
0.01 |
|
|
|
(0.04 |
) |
|
NM |
|
Income tax provision, as adjusted (8) |
|
|
0.01 |
|
|
|
0.06 |
|
|
|
(0.05 |
) |
|
(83.3 |
) % |
Adjusted Diluted EPS (Non-GAAP)(10) |
|
$ |
0.38 |
|
|
$ |
0.10 |
|
|
$ |
0.28 |
|
|
NM |
|
|
|
|
|
|
|
|
|
|
|||||||
Weighted-average diluted shares outstanding (Non- GAAP) (11) |
|
|
250,466,861 |
|
|
|
220,373,388 |
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|||||||
Gross profit (GAAP) |
|
$ |
1,242 |
|
|
$ |
1,008 |
|
|
$ |
234 |
|
|
23.2 |
% |
LIFO reserve adjustments (2) |
|
|
15 |
|
|
|
16 |
|
|
|
(1 |
) |
|
(6.3 |
) % |
COVID-19 product donations and inventory adjustments (5) |
|
|
— |
|
|
|
10 |
|
|
|
(10 |
) |
|
(100.0 |
) % |
Adjusted Gross profit (Non-GAAP) |
|
$ |
1,257 |
|
|
$ |
1,034 |
|
|
$ |
223 |
|
|
21.6 |
% |
|
|
|
|
|
|
|
|
|
|||||||
Operating expenses (GAAP) |
|
$ |
1,105 |
|
|
$ |
978 |
|
|
$ |
127 |
|
|
13.0 |
% |
Depreciation expense |
|
|
(81 |
) |
|
|
(86 |
) |
|
|
5 |
|
|
(5.8 |
) % |
Amortization expense |
|
|
(11 |
) |
|
|
(20 |
) |
|
|
9 |
|
|
(45.0 |
) % |
Share-based compensation expense (1) |
|
|
(12 |
) |
|
|
(11 |
) |
|
|
(1 |
) |
|
9.1 |
% |
Business transformation costs (3) |
|
|
(5 |
) |
|
|
(14 |
) |
|
|
9 |
|
|
(64.3 |
) % |
COVID-19 bad debt expense (4) |
|
|
— |
|
|
|
18 |
|
|
|
(18 |
) |
|
(100.0 |
) % |
COVID-19 other related expenses (6) |
|
|
(2 |
) |
|
|
2 |
|
|
|
(4 |
) |
|
(200.0 |
) % |
Business acquisition and integration related costs and other (7) |
|
|
8 |
|
|
|
(2 |
) |
|
|
10 |
|
|
NM |
|
Adjusted Operating expenses (Non-GAAP) |
|
$ |
1,002 |
|
|
$ |
865 |
|
|
$ |
137 |
|
|
15.8 |
% |
NM - Not Meaningful |
||
(1) |
Share-based compensation expense for expected vesting of stock awards and employee stock purchase plan. |
|
(2) |
Represents the non-cash impact of LIFO reserve adjustments. |
|
(3) |
Consists primarily of costs related to significant process and systems redesign across multiple functions. |
|
(4) |
Includes the changes in the reserve for doubtful accounts expense reflecting the collection risk associated with our customer base as a result of the COVID-19 pandemic. |
|
(5) |
Includes COVID-19 related expenses related to inventory adjustments and product donations. |
|
(6) |
Includes COVID-19 costs that we are permitted to addback under certain agreements governing our indebtedness. |
|
(7) |
Includes: (i) aggregate acquisition and integration related costs of |
|
(8) |
Represents our income tax provision (benefit) adjusted for the tax effect of pre-tax items excluded from Adjusted Net income and the removal of applicable discrete tax items. Applicable discrete tax items include changes in tax laws or rates, changes related to prior year unrecognized tax benefits, discrete changes in valuation allowances, and excess tax benefits associated with share-based compensation. The tax effect of pre-tax items excluded from Adjusted net income is computed using a statutory tax rate after taking into account the impact of permanent differences and valuation allowances. |
|
(9) |
Effective as of the first quarter 2021, we have presented Adjusted net income. Previously, we presented Adjusted net income available to common shareholders. |
|
(10) |
Adjusted Diluted EPS is calculated as Adjusted net income divided by weighted average diluted shares outstanding (Non-GAAP), see note 11. Prior period amounts have been revised to conform with current year presentation. |
|
(11) |
For purposes of the Adjusted Diluted EPS calculation (Non-GAAP), when the Company has net income (GAAP), weighted average diluted shares outstanding (Non-GAAP) is used and assumes conversion of the Series A convertible preferred stock, and, when the Company has net loss (GAAP) and assumed conversion of the Series A convertible preferred stock would be antidilutive, weighted-average diluted shares outstanding (GAAP) is used. |
Non-GAAP Reconciliation (Unaudited) |
|||||||||||||||
|
|
For the year ended |
|||||||||||||
|
|
Consolidated |
|||||||||||||
($ in millions, except share and per share data) |
|
|
|
|
|
Change |
|
% |
|||||||
Net income (loss) available to common shareholders (GAAP) |
|
$ |
121 |
|
|
$ |
(254 |
) |
|
$ |
375 |
|
|
(147.6 |
) % |
Series A Preferred Stock Dividends |
|
|
(43 |
) |
|
|
(28 |
) |
|
|
(15 |
) |
|
53.6 |
% |
Net income (loss) (GAAP) |
|
|
164 |
|
|
|
(226 |
) |
|
|
390 |
|
|
(172.6 |
) % |
Interest expense—net |
|
|
213 |
|
|
|
238 |
|
|
|
(25 |
) |
|
(10.5 |
) % |
Income tax provision (benefit) |
|
|
50 |
|
|
|
(68 |
) |
|
|
118 |
|
|
(173.5 |
) % |
Depreciation expense |
|
|
323 |
|
|
|
343 |
|
|
|
(20 |
) |
|
(5.8 |
) % |
Amortization expense |
|
|
55 |
|
|
|
79 |
|
|
|
(24 |
) |
|
(30.4 |
) % |
EBITDA (Non-GAAP) |
|
|
805 |
|
|
|
366 |
|
|
|
439 |
|
|
119.9 |
% |
Adjustments: |
|
|
|
|
|
|
|
|
|||||||
Restructuring costs and asset impairment charges (1) |
|
|
11 |
|
|
|
39 |
|
|
|
(28 |
) |
|
(71.8 |
) % |
Share-based compensation expense (2) |
|
|
48 |
|
|
|
40 |
|
|
|
8 |
|
|
20.0 |
% |
LIFO reserve adjustments (3) |
|
|
165 |
|
|
|
25 |
|
|
|
140 |
|
|
NM |
|
Loss on extinguishment of debt (4) |
|
|
23 |
|
|
|
— |
|
|
|
23 |
|
|
NM |
|
Business transformation costs (5) |
|
|
22 |
|
|
|
22 |
|
|
|
— |
|
|
— |
% |
COVID-19 bad debt (benefit) expense (6) |
|
|
(15 |
) |
|
|
47 |
|
|
|
(62 |
) |
|
(131.9 |
) % |
COVID-19 product donations and inventory adjustments (7) |
|
|
— |
|
|
|
50 |
|
|
|
(50 |
) |
|
(100.0 |
) % |
COVID-19 other related expenses (8) |
|
|
3 |
|
|
|
13 |
|
|
|
(10 |
) |
|
(76.9 |
) % |
Business acquisition and integration related costs and other (9) |
|
|
(5 |
) |
|
|
46 |
|
|
|
(51 |
) |
|
(110.9 |
) % |
Adjusted EBITDA (Non-GAAP) |
|
|
1,057 |
|
|
|
648 |
|
|
|
409 |
|
|
63.1 |
% |
Depreciation expense |
|
|
(323 |
) |
|
|
(343 |
) |
|
|
20 |
|
|
(5.8 |
) % |
Interest expense—net |
|
|
(213 |
) |
|
|
(238 |
) |
|
|
25 |
|
|
(10.5 |
) % |
Income tax provision, as adjusted (10) |
|
|
(133 |
) |
|
|
(19 |
) |
|
|
(114 |
) |
|
NM |
|
Adjusted Net income (Non-GAAP) (11) |
|
$ |
388 |
|
|
$ |
48 |
|
|
$ |
340 |
|
|
NM |
|
|
|
|
|
|
|
|
|
|
|||||||
Diluted EPS (GAAP) |
|
$ |
0.54 |
|
|
$ |
(1.15 |
) |
|
$ |
1.69 |
|
|
(147.0 |
) % |
Restructuring costs and asset impairment charges (1) |
|
|
0.04 |
|
|
|
0.18 |
|
|
|
(0.14 |
) |
|
(77.8 |
) |
Share-based compensation expense (2) |
|
|
0.19 |
|
|
|
0.18 |
|
|
|
0.01 |
|
|
5.6 |
% |
LIFO reserve adjustments (3) |
|
|
0.66 |
|
|
|
0.11 |
|
|
|
0.55 |
|
|
NM |
|
Loss on extinguishment of debt (4) |
|
|
0.09 |
|
|
|
— |
|
|
|
0.09 |
|
|
NM |
|
Business transformation costs (5) |
|
|
0.09 |
|
|
|
0.10 |
|
|
|
(0.01 |
) |
|
(10.0 |
) % |
COVID-19 bad debt (benefit) expense (6) |
|
|
(0.06 |
) |
|
|
0.21 |
|
|
|
(0.27 |
) |
|
(128.6 |
) % |
COVID-19 product donations and inventory adjustments (7) |
|
|
— |
|
|
|
0.23 |
|
|
|
(0.23 |
) |
|
(100.0 |
) % |
COVID-19 other related expenses (8) |
|
|
0.01 |
|
|
|
0.06 |
|
|
|
(0.05 |
) |
|
(83.3 |
) % |
Business acquisition and integration related costs and other (9) |
|
|
(0.02 |
) |
|
|
0.21 |
|
|
|
(0.23 |
) |
|
(109.5 |
) % |
Income tax provision, as adjusted (10) |
|
|
0.01 |
|
|
|
0.09 |
|
|
|
(0.08 |
) |
|
NM |
|
Adjusted Diluted EPS (Non-GAAP) (12) |
|
$ |
1.55 |
|
|
$ |
0.22 |
|
|
$ |
1.33 |
|
|
NM |
|
|
|
|
|
|
|
|
|
|
|||||||
Weighted-average diluted shares outstanding (Non-GAAP) (13) |
|
|
249,886,068 |
|
|
|
219,838,120 |
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|||||||
Gross profit (GAAP) |
|
$ |
4,655 |
|
|
$ |
3,719 |
|
|
$ |
936 |
|
|
25.2 |
% |
LIFO reserve adjustments (3) |
|
|
165 |
|
|
|
25 |
|
|
|
140 |
|
|
NM |
|
COVID-19 product donations and inventory adjustments (7) |
|
|
— |
|
|
|
50 |
|
|
|
(50 |
) |
|
(100.0 |
) |
Adjusted Gross profit (Non-GAAP) |
|
$ |
4,820 |
|
|
$ |
3,794 |
|
|
$ |
1,026 |
|
|
27.0 |
% |
|
|
|
|
|
|
|
|
|
|||||||
Operating expenses (GAAP) |
|
$ |
4,231 |
|
|
$ |
3,796 |
|
|
$ |
435 |
|
|
11.5 |
% |
Depreciation expense |
|
|
(323 |
) |
|
|
(343 |
) |
|
|
20 |
|
|
(5.8 |
) % |
Amortization expense |
|
|
(55 |
) |
|
|
(79 |
) |
|
|
24 |
|
|
(30.4 |
) % |
Restructuring costs and asset impairment charges (1) |
|
|
(11 |
) |
|
|
(39 |
) |
|
|
28 |
|
|
(71.8 |
) % |
Share-based compensation expense (2) |
|
|
(48 |
) |
|
|
(40 |
) |
|
|
(8 |
) |
|
20.0 |
% |
Business transformation costs (5) |
|
|
(22 |
) |
|
|
(22 |
) |
|
|
— |
|
|
— |
% |
COVID-19 bad debt benefit (expense) (6) |
|
|
15 |
|
|
|
(47 |
) |
|
|
62 |
|
|
(131.9 |
) % |
COVID-19 other related expenses (8) |
|
|
(3 |
) |
|
|
(13 |
) |
|
|
10 |
|
|
(76.9 |
) % |
Business acquisition and integration related costs and other (9) |
|
|
5 |
|
|
|
(46 |
) |
|
|
51 |
|
|
(110.9 |
) % |
Adjusted Operating expenses (Non-GAAP) |
|
$ |
3,789 |
|
|
$ |
3,167 |
|
|
$ |
622 |
|
|
19.6 |
% |
NM - Not Meaningful |
||
(1) |
Consists primarily of severance and related costs, organizational realignment costs and asset impairment charges. |
|
(2) |
Share-based compensation expense for expected vesting of stock awards and employee stock purchase plan. |
|
(3) |
Represents the non-cash impact of LIFO reserve adjustments. |
|
(4) |
Includes early redemption premium and the write-off of certain pre-existing debt issuance costs. |
|
(5) |
Consists primarily of costs related to significant process and systems redesign across multiple functions. |
|
(6) |
Includes the changes in the reserve for doubtful accounts expense reflecting the collection risk associated with our customer base as a result of the COVID-19 pandemic. |
|
(7) |
Includes COVID-19 related expenses related to inventory adjustments and product donations. |
|
(8) |
Includes COVID-19 costs that we are permitted to addback under certain agreements governing our indebtedness. |
|
(9) |
Includes: (i) aggregate acquisition and integration related costs of |
|
(10) |
Represents our income tax provision (benefit) adjusted for the tax effect of pre-tax items excluded from Adjusted Net income available to common shareholders and the removal of applicable discrete tax items. Applicable discrete tax items include changes in tax laws or rates, changes related to prior year unrecognized tax benefits, discrete changes in valuation allowances, and excess tax benefits associated with share-based compensation. The tax effect of pre-tax items excluded from Adjusted net income available to common shareholders is computed using a statutory tax rate after taking into account the impact of permanent differences and valuation allowances. |
|
(11) |
Effective as of the first quarter 2021, we have presented Adjusted net income. Previously, we presented Adjusted net income available to common shareholders. |
|
(12) |
Adjusted Diluted EPS is calculated as Adjusted net income divided by weighted average diluted shares outstanding (Non-GAAP), see note 13. Prior period amounts have been revised to conform with current year presentation. |
|
(13) |
For purposes of the Adjusted Diluted EPS calculation (Non-GAAP), when the Company has net income (GAAP), weighted average diluted shares outstanding (Non-GAAP) is used and assumes conversion of the Series A convertible preferred stock, and, when the Company has net loss (GAAP) and assumed conversion of the Series A convertible preferred stock would be antidilutive, weighted-average diluted shares outstanding (GAAP) is used. |
Non-GAAP Reconciliation Net Debt and Net Leverage Ratios |
||||||||
($ in millions, except ratios) |
|
|
|
|
||||
Total Debt (GAAP) |
|
$ |
5,011 |
|
|
$ |
5,748 |
|
Cash, cash equivalents and restricted cash |
|
|
(148 |
) |
|
|
(828 |
) |
Net Debt (Non-GAAP) |
|
$ |
4,863 |
|
|
$ |
4,920 |
|
Adjusted EBITDA (1) |
|
$ |
1,057 |
|
|
$ |
648 |
|
Net Leverage Ratio (2) |
|
|
4.6 |
|
|
|
7.6 |
|
(1) Trailing Twelve Months (TTM) Adjusted EBITDA |
||||||||
(2) Net Debt/TTM Adjusted EBITDA |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220216006316/en/
INVESTOR CONTACT:
(847) 720-2767
Melissa.Napier@usfoods.com
MEDIA CONTACT:
(847) 720-2392
Sara.Matheu@usfoods.com
Source:
FAQ
What were USFD's fourth quarter results for 2021?
What is the outlook for US Foods in fiscal year 2022?
How did USFD perform in terms of case volume for 2021?
What was the Adjusted EBITDA for US Foods in 2021?